Please be aware of the following dates and meetings (or lack thereof) during December, 2013:
December 31, 2013
Dark for lunch (no meeting)
December 24, 2013
Dark for lunch (no meeting)
December 17, 2013
Dark for lunch (no meeting). Holiday Party, 6pm, La Valencia Hotel
A native of Sydney, Australia, Concetta K. Antico is a Contemporary tetrachromist who has painted with oils since childhood. She has been a leader in the San Diego art community for over 20 years as artist and instructor.
A well-respected teacher, she has taught oil painting through her Salon of Art Studio to thousands of students of all ages.
As an artist, Concetta has been known for her use of intense color and values. For years, most just thought her use of color was her “style” but come to find out, there is actually a scientific reason. Concetta was recently diagnosed with Tetrachromacy. Tetrachromacy is the condition of possessing four independent channels for conveying color information, or possessing four different types of cone cells in the eye.
Human beings with tetrachromacy are called tetrachromats, hence why Concetta is considered to be a Tetrachromat Artist. Most people have three cones in their eye, a color blind person would have two. To have four is incredibly rare, in fact studies show that only 2-3% of the world population is thought to be tetrachromatic. Concetta is currently in a study with researches in several medical centers all over California. Results of the research groups will be released in early 2014.
Rick Itzkowich is the President of 501 Connections Inc. He is a genuine people connector. He bridges the two worlds of face-to-face networking and online networking. He understands and practices networking like few others do. Rick speaks to a diverse group of organizations.
Internationally Rick earned the Best Speaker Award at the “You Learn Twit Face” international social media conference held in Dubai. As a successful entrepreneur, Rick creates turnkey products that meet today’s demand for tools to increase your business.
His products include QuoteActions, Link Power Coaching, Rock IT! Referrals and the new YIKES! business networking workshops. He is a Vistage Chair and regular SCORE presenter. Feel free to connect with Rick on LinkedIn. http://www.linkedin.com/in/ritzkowich.com
Conventional drugs used to treat virus infections target only a single virus at any one time, and, since these viruses can mutate rapidly, these drug treatments are often associated with virus resistance to treatment. A new approach that we are developing targets critical functions in the host instead. Since these functions are involved in supporting, or defending against, multiple different viruses, these approaches offer the potential to eliminate a large number of virus infections using a single drug. We also predict that these drugs will be less susceptible to the development of viral drug resistance. I will discuss our progress toward identifying host targets for these so-called broad spectrum antiviral drugs.
John A. T. Young, a Professor in the Nomis Foundation Laboratories for Immunobiology and Microbial Pathogenesis, studies the cell biology of virus infection and anthrax intoxication. His laboratory is identifying and characterizing cellular factors that contribute to the early steps of infection by HIV and other retroviruses, influenza virus, and filoviruses such as Ebola virus. These studies are giving novel insights into virus-host interactions and are suggesting new therapeutic strategies for combating virus infection. The Young laboratory has also identified both known cellular receptors for anthrax toxin. Current research in the lab is aimed at understanding how these receptors, along with other cellular factors, regulate anthrax toxin entry into cells. Soluble versions of a cellular receptor are also being developed as receptor decoys to efficiently neutralize anthrax toxin.
A major goal of our work is to reveal how host cell proteins either contribute to or defend against infection by important human microbial pathogens, such as HIV, influenza virus, Ebola virus and the bacterium that causes anthrax. Knowledge of the roles played by this cellular machinery provides new insights into the cell biology of microbial infections and could suggest new broad-spectrum antimicrobial approaches.”
A major focus of Young’s work is on the HIV virus. HIV/AIDS continues to be a serious global problem. The virus can remain “hidden” in a latent form in infected individuals for years, even after long-term suppression with highly active antiretroviral therapy. Moreover, viral drug resistance represents a formidable problem, creating an urgent need for new classes of antiretrovirals.
ljrc2016word.wordpress.com 